超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

Sequenta  
LymphoSIGHT（淋巴細胞免疫球蛋白和T細胞受體測序）平臺由Sequenta設計，是對免疫細胞計數的一個平臺。用于ALL、慢性淋巴細胞白血?。–LL）和套細胞淋巴瘤。
LymphoSIGHT是一個新型的流式細胞儀，但靈敏度和特異性提高。與流式細胞儀不同的是，LymphoSIGHT可以測定免疫細胞的DNA含量，DNA含量具有很強的適應性，使細胞根據需求產生抗體。“這是遺傳多樣性的引擎，有萬億種不同組合。這些免疫細胞會產生獨特的DNA標簽，因此可以確定樣本中免疫細胞的特點，” Sequenta執行總裁Tom Willis博士說。

Sequenta is a venture-backed company dedicated to improving patient care in diseases mediated by immune cells through measurements of lymphocyte diversity. It is commercializing its LymphoSIGHT? platform for clinical use in minimal residual disease while continuing to validate the use of its technology in a diverse set of diseases.